Kitsawet Saethao
- GSK plc (NYSE:GSK) said on Friday that the European Medicines Agency (EMA) has accepted its marketing application to expand the use of its respiratory syncytial virus vaccine to include adults from 18 years of age.
- European regulatory decision for the
